Background: The use of intraoperative parathyroid hormone (ioPTH) during surgery for primary hyperparathyroidism (PHPT) has become widely available as a tool to monitor the success of the procedure. The aim of our study was to correlate the decrease of ioPTH with long term outcome in patients with PHPT.